SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-00-004211
Filing Date
2000-05-01
Accepted
2000-05-01 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 CLINICHEM DEVELOPMENT INC. SC 13D 11771
  Complete submission text file 0000950123-00-004211.txt   13591
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filed by) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 275 ARMAND FRAPPIER BOULEVARD LAVAL PROVICE QUEBEC A8 00000 5146811744
CLINICHEM DEVELOPMENT INC (Subject) CIK: 0001054396 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-54385 | Film No.: 615541
SIC: 2834 Pharmaceutical Preparations